Literature DB >> 12701804

Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation.

Kazumasa Aoyagi1.   

Abstract

We have reported that (1) the synthesis of GSA, a uremic toxin, increases depending on the urea concentration and (2) GSA is formed from argininosuccinic acid (ASA) and the hydroxyl radical or SIN-1 which generates superoxide and NO simultaneously. However, an excess of NO, which also serves as a scavenger of the hydroxyl radical, inhibited GSA synthesis. We also reported that arginine, citrulline or ammonia plus ornithine, all of which increase arginine, inhibit GSA synthesis even in the presence of urea. To elucidate the mechanism for increased GSA synthesis by urea, we investigated the effect of urea on ASA and arginine, the immediate precursor of NO. Isolated rat hepatocytes were incubated in 6 ml of Krebs-Henseleit bicarbonate buffer containing 3% bovine serum albumin, 10 mM sodium lactate, 10 mM ammonium chloride and with or without 36 mM of urea and 0.5 or 5 mM ornithine at 37 degrees C for 20 min. In vivo experiments, 4 ml/100 g body weight of 1.7 M urea or 1.7 M NaCl were injected intra-peritoneally into 5 male Wistar rats. Two hours after the intra-peritoneal injection of urea or 1.7 M NaCl, blood, liver and kidney were obtained by the freeze cramp method and amino acids were determined by an amino acid analyzer (JEOL:JCL-300). ASA in isolated hepatocytes was not detected with or without 36 mM (200 mgN/dl) urea, but the arginine level decreased from 36 to 33 nmol/g wet cells with urea. Ornithine which inhibits GSA synthesis, increased ASA markedly in a dose dependent manner and increased arginine. At 2 h after the urea injection the rat serum arginine level decreased by 42% (n = 5), and ornithine and citrulline levels increased significantly. Urea injection increased the ASA level in liver from 36-51 nmol/g liver but this was not statistically significant. We propose that urea inhibits arginine synthesis in hepatocytes, where the arginine level is extremely low to begin with, which decreases NO production which, in turn, increases hydroxyl radical generation from superoxide and NO. This may, also, be an explanation for the reported increase in oxygen stress in renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701804

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  17 in total

1.  Synthesis of guanidinosuccinate from argininosuccinate and reactive oxygen in vitro.

Authors:  K Aoyagi; S Nagase; C Tomida; K Takemura; K Akiyama; A Koyama
Journal:  Enzyme Protein       Date:  1996

2.  Role of reactive oxygen and argininosuccinate in guanidinosuccinate synthesis in isolated rat hepatocytes.

Authors:  K Aoyagi; S Nagase; M Gotoh; K Akiyama; M Satoh; A Hirayama; A Koyama
Journal:  Enzyme Protein       Date:  1996

3.  Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance.

Authors:  S Nagase; K Aoyagi; A Hirayama; M Gotoh; A Ueda; C Tomida; T Kamezaki; Y Nagai; H Kikuchi; A Koyama
Journal:  J Am Soc Nephrol       Date:  1997-07       Impact factor: 10.121

4.  Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.

Authors:  J D Kopple; S I Gordon; M Wang; M E Swendseid
Journal:  J Lab Clin Med       Date:  1977-08

5.  Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes.

Authors:  K Aoyagi; S Nagase; M Narita; S Tojo
Journal:  Kidney Int Suppl       Date:  1987-10       Impact factor: 10.545

6.  Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia.

Authors:  S Giovannetti; L Cioni; P L Balestri; M Biagnini
Journal:  Clin Sci       Date:  1968-02       Impact factor: 6.124

7.  Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.

Authors:  H I Horowitz; I M Stein; B D Cohen; J G White
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

8.  Serum antioxidant activity in uremic patients.

Authors:  M Kuroda; S Asaka; Y Tofuku; R Takeda
Journal:  Nephron       Date:  1985       Impact factor: 2.847

9.  Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.

Authors:  R D'Hooge; Y Q Pei; B Marescau; P P De Deyn
Journal:  J Neurol Sci       Date:  1992-10       Impact factor: 3.181

10.  N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioural and electrophysiological evidence.

Authors:  R D'Hooge; A Raes; P Lebrun; M Diltoer; P P Van Bogaert; J Manil; F Colin; P P De Deyn
Journal:  Neuropharmacology       Date:  1996-04       Impact factor: 5.250

View more
  9 in total

Review 1.  Methyl group deficiency and guanidino production in uremia.

Authors:  Burton D Cohen
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 2.  Optimizing therapy for argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Brendan Lee; Ayelet Erez
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

3.  Quantitative determination of urea concentrations in cell culture medium.

Authors:  Robert J X Zawada; Peggy Kwan; Kellen L Olszewski; Manuel Llinas; Shu-Gui Huang
Journal:  Biochem Cell Biol       Date:  2009-06       Impact factor: 3.626

Review 4.  Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.

Authors:  Ayelet Erez; Sandesh C Sreenath Nagamani; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-02-10       Impact factor: 3.908

5.  Intervention of Ayurvedic drug Tinospora cordifolia attenuates the metabolic alterations in hypertriglyceridemia: a pilot clinical trial.

Authors:  Amey Shirolkar; Aarti Yadav; T K Mandal; Rajesh Dabur
Journal:  J Diabetes Metab Disord       Date:  2020-10-16

Review 6.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19

7.  Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.

Authors:  Masanori Tachikawa; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-02-28

Review 8.  The Potential of L-Arginine in Prevention and Treatment of Disturbed Carbohydrate and Lipid Metabolism-A Review.

Authors:  Aleksandra Szlas; Jakub Michał Kurek; Zbigniew Krejpcio
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

Review 9.  Argininosuccinate lyase deficiency.

Authors:  Sandesh C S Nagamani; Ayelet Erez; Brendan Lee
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.